Acupuncture (superficial dry-needling) as a treatment for chronic postherpetic neuralgia – a randomized clinical trial

Sollie et al. · British Journal of Pain · 2022

🔬Double-Blind RCT👥n=26 participantsModerate Evidence

Evidence Level

MODERATE
65/ 100
Quality
4/5
Sample
2/5
Replication
3/5
🎯

OBJECTIVE

To investigate whether superficial acupuncture is more effective than sham treatment for chronic postherpetic pain

👥

WHO

26 patients with chronic postherpetic neuralgia (pain for more than 6 months)

⏱️

DURATION

2 sessions over 2 consecutive weeks, 1-month follow-up

📍

POINTS

Superficial needling at the facet joints of the affected dermatome, depth 5–10 mm

🔬 Study Design

26participants
randomization

Real acupuncture

n=11

Superficial needling at the facet joints

Sham acupuncture

n=15

Blunt needles pressed against the skin without penetration

⏱️ Duration: 2 weeks of treatment + 4 weeks of follow-up

📊 Results in numbers

-1.2 points

Maximum pain — acupuncture group

-0.9 points

Maximum pain — control group

-0.5 points

Mean pain — both groups

p > 0.05

Between-group difference

p = 0.03

Quality of life — emotional problems

📊 Outcome Comparison

Reduction in maximum pain (0–10 scale)

Acupuncture
1.2
Sham
0.9
💬 What does this mean for you?

This study tested whether superficial acupuncture helps patients with chronic pain after shingles (herpes zoster). Researchers compared real acupuncture with sham acupuncture and found that both reduced pain to a similar degree, suggesting that the effect may be primarily a placebo effect.

📝

Article summary

Plain-language narrative summary

Postherpetic neuralgia (PHN) is a painful condition that affects between 5% and 30% of people after an episode of herpes zoster (shingles) and may persist for up to 10 years. This chronic pain is a major therapeutic challenge, as many patients do not achieve adequate relief from the conventional treatments available, which include topical agents such as lidocaine and capsaicin, anticonvulsants, tricyclic antidepressants, and opioids. Faced with this therapeutic gap, many patients and clinicians turn to acupuncture as an alternative treatment, although robust scientific evidence on its efficacy was lacking. This study is the first randomized clinical trial to rigorously investigate the effects of superficial acupuncture (dry needling) for the treatment of PHN, using a control group with an adequate sham procedure.

The investigators conducted a double-blind, randomized, placebo-controlled, two-arm clinical trial. Twenty-six patients with chronic PHN (pain persisting for more than 6 months after the shingles episode) were randomized to receive either real or sham acupuncture. The intervention group received superficial needling at the facet joints corresponding to the affected dermatome, with 0.25 mm × 13 mm needles inserted to a depth of 5–10 mm at a 45-degree angle, left in situ for 5 minutes. The control group received a sham procedure using blunt needles pressed against the skin without penetration.

All participants received two treatment sessions in consecutive weeks and were assessed at baseline and one month after the final treatment. Outcome measures included numeric pain rating scales (0–10), the Neuropathic Pain Symptom Inventory (NPSI), and the SF-36 quality-of-life questionnaire. Blinding was successful, with participants unable to distinguish between real and sham treatments. The results showed that both groups experienced similar and modest reductions in pain levels.

In the real acupuncture group, maximum pain decreased from 8.5 to 7.3 points (a 1.2-point reduction), while mean pain decreased from 6.2 to 5.7 points (a 0.5-point reduction). In the control group, maximum pain decreased from 8.3 to 7.4 points (a 0.9-point reduction) and mean pain from 7.1 to 6.6 points (a 0.5-point reduction). Crucially, no statistically significant between-group differences were detected for any pain measure (p > 0.05). Among the neuropathic pain parameters assessed by the NPSI (superficial spontaneous pain, deep spontaneous pain, paroxysmal pain, evoked pain, and paresthesia/dysesthesia), none showed significant between-group differences.

The only parameter that reached statistical significance was a quality-of-life measure related to 'role limitations due to emotional problems' (p = 0.03), where the acupuncture group showed improvement while the control group worsened. This isolated finding may reflect an effect of acupuncture on emotional well-being, consistent with prior literature on acupuncture and mental health, although more research is needed. The clinical implications of this study are important for patients and clinicians. The results suggest that, while some individual patients may experience pain relief with acupuncture, there is insufficient evidence to support its routine use in PHN treatment.

The absence of significant differences between real and sham acupuncture indicates that any observed benefit may be primarily due to placebo effects, including therapeutic attention, patient expectations, and the ritual of treatment. This study has several important limitations. The relatively small sample size (26 participants) may have been insufficient to detect clinically meaningful differences. The limited number of treatments (only two sessions) may have been inadequate, since meta-analyses suggest that six or more sessions are associated with better outcomes.

Mean symptom duration in participants was approximately 5 years, and patients with more recent symptoms might respond better. In addition, several participants had previously tried acupuncture without success, which could have influenced their expectations.

Strengths

  • 1First RCT with adequate sham control for PHN
  • 2Rigorous double-blind design with successful blinding
  • 3Methodology following CONSORT guidelines
  • 4Multiple validated outcome measures
⚠️

Limitations

  • 1Small sample size (n=26)
  • 2Only 2 treatment sessions
  • 3Long symptom duration (mean 5 years)
  • 4Some participants had already tried acupuncture without success
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Postherpetic neuralgia is one of the most refractory chronic pain conditions we see in pain practice. The pharmacologic armamentarium — gabapentinoids, tricyclics, topical lidocaine, high-concentration capsaicin — frequently provides only partial relief, and a meaningful proportion of patients remain with elevated pain scores after years of optimized treatment. In this scenario, acupuncture repeatedly comes up as a patient request and as an option raised by treating physicians. What this trial offers, concretely, is the first controlled estimate of the specific effect of superficial needling in this population. By demonstrating modest and similar reductions between real and sham acupuncture, the study provides a basis for a more honest conversation with the patient about realistic expectations — without ruling out the procedure for those who seek any incremental gain in quality of life, but calibrating the indication within a multimodal plan.

Notable Findings

The finding that deserves attention is not the absence of an analgesic difference between groups — expected by most neuropathic pain specialists — but rather the statistically significant improvement in the SF-36 'role limitations due to emotional problems' domain exclusively in the real acupuncture group (p = 0.03), while the sham group worsened in that same domain. In patients with PHN established for about five years, the emotional dimension of chronic pain is often as disabling as the pain itself, and interventions that move this parameter deserve clinical attention. In addition, the success of blinding — with participants unable to distinguish real from sham acupuncture — gives the design methodologic robustness rare in acupuncture trials, which makes the absence of a differential analgesic effect a more reliable finding than is usual in this literature.

From My Experience

In my rehabilitation and pain practice, long-standing PHN — patients who arrive with five or six years of symptoms, having already gone through multiple pharmacologic regimens — represents the most challenging scenario for any nonpharmacologic intervention. I have observed that, when I propose acupuncture in this profile, the objective analgesic response tends to be modest and variable, appearing, when it does, after four to six sessions. What patients frequently report, and which coincides with the emotional finding of this trial, is a feeling of greater control over the condition and reduction in anticipatory anxiety about pain — which on its own already justifies inclusion in a multimodal plan. I usually combine needling with progressive topical desensitization and, when mechanical allodynia predominates, with low-frequency electrical stimulation. The profile that responds best, in my experience, is the patient with a moderate central-sensitization component, without a history of multiple acupuncture failures — exactly the subgroup that this study, inadvertently, excluded by including previously refractory cases.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

British Journal of Pain · 2022

DOI: 10.1177/20494637211023075

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.